Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667118 | PMC |
| http://dx.doi.org/10.1016/j.hrcr.2023.08.014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Successfully escaping the pleura with the extra-vascular implantable cardioverter defibrillator lead: a case report.
Eur Heart J Case Rep
July 2025
Department of Electrophysiology, AZ Sint-Jan Hospital, Ruddershove 10, Bruges B-8000, Belgium.
Background: Extra-vascular implantable cardioverter defibrillator (EV-ICD) is an emerging technique for ICD implantation with substernal lead placement. The system avoids the vasculature and can deliver anti-tachycardia and pause prevention pacing, with a generator size smaller than the existing subcutaneous device. While this device is now widely available, little is known about potential complications that may follow its implantation in real life context.
View Article and Find Full Text PDFImplantation and Follow-Up of an Extravascular ICD After a Challenging Transvenous System Extraction: A Case Report.
Pacing Clin Electrophysiol
April 2025
Cardiochirurgia Universitaria - Policlinico di Bari, Bari, Italy.
The Extravascular ICD (EV-ICD) is implanted outside of the patient's heart and vascular system. The defibrillation lead is tunneled in the substernal space, very close to the surface of the heart, thus allowing for additional pacing capabilities such as Post Shock Pacing, Anti-Tachycardia Pacing (ATP), and Pause Prevention Pacing. Early studies demonstrated the safety and efficacy profile of the EV-ICD, but patients with previous or existing cardiac devices or leads were excluded.
View Article and Find Full Text PDFRisk of VF Undersensing in Extra-Vascular ICD Due to Concomitant Leadless Pacing.
Annu Int Conf IEEE Eng Med Biol Soc
July 2024
Extravascular implantable cardioverter-defibrillators (EV-ICD) offer defibrillation, anti-tachycardia pacing (ATP), and backup pacing, packaged in a unit comparable to traditional transvenous ICDs in size, shape, and longevity. However, the pacing capabilities of EV-ICD are restricted to ATP, pause prevention and post-shock pacing. For EV-ICD patients who develop the need for pacing, having a concomitant leadless pacemaker such as Micra could provide the needed pacing support.
View Article and Find Full Text PDFPause-prevention pacing in an extravascular implantable cardioverter-defibrillator.
HeartRhythm Case Rep
November 2023
Medtronic, Inc., Mounds View, Minnesota.
Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.
N Engl J Med
October 2022
From Mayo Clinic, Rochester (P.F.), and Medtronic, Mounds View (A.E.T., C.W., S.W.) - both in Minnesota; King's College Hospital, London (F.M.); the Cardiology Department, St. Antonius Hospital, Nieuwegein (L.V.A.B.), and Amsterdam University Medical Centers, Amsterdam (L.V.A.B., R.E.K.) - both in t
Background: The extravascular implantable cardioverter-defibrillator (ICD) has a single lead implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and defibrillation energy similar to that of transvenous ICDs. The safety and efficacy of extravascular ICDs are not yet known.
Methods: We conducted a prospective, single-group, nonrandomized, premarket global clinical study involving patients with a class I or IIa indication for an ICD, all of whom received an extravascular ICD system.